Levels of antihypertensive use were generally similar in participants with and without physiological hypertension, except for higher use of ACE inhibitors (37.0% vs 29.3%) in supine normotensives compared to supine hypertensives (S1 Table). The gene discussed is ACE; the disease is Hypertension.